Rachana Shah
Assistant Professor of Clinical Pediatrics
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (11)
Year:
2026
LBSeq4Kids is a clinically validated liquid biopsy platform combining low passage whole genome sequencing (LP-WGS) for copy number alterations (CNAs) and a custom cancer targeted sequencing panel (TSP) to detect sequence variants in cell-free DNA from the aqueous humor (AH) of the eye, cerebrospinal fluid, and plasma. We present LBSeq4Kids results from a prospective cohort of 60 ocular oncology patients, including 41 with retinoblastoma (RB),13 with non-malignant RB simulating lesions and six with other intraocular malignancies. Ninety-four percent of baseline RB samples obtained at diagnosis were positive for CNAs by LP-WGS and 83% were positive for pathogenic variants by TSP analysis. All samples obtained at clinical recurrence were positive for ctDNA whereas none of the eyes in remission had a positive finding. The presence of CNAs detected by serial sampling in patients being treated for RB was correlated with clinical disease status. None of the patients with RB-simulating lesions had a positive finding by LP-WGS. The sensitivity of the assay to detect ctDNA in the setting of active RB was 98%. LBSeq4Kids represents a groundbreaking improvement for intraocular malignancies and is highly effective in informing accurate diagnosis, risk stratification, response to therapy, and surveillance.
Year:
2026
Year:
2025
Although giant cell lesions (GCLs) of the maxillofacial (MF) and axial/appendicular (AA) skeleton are managed as distinct entities, the comparative outcomes of these approaches remain uncertain. The pediatric population is particularly understudied, despite unique management considerations and the need to minimize surgical morbidity. This study compares characteristics and long-term outcomes of MF and AA GCL management in a pediatric and adolescent population. A retrospective cohort study of patients with histologically confirmed GCLs from 2002 to 2024 was conducted. MF lesions were designated aggressive or nonaggressive by Chuong and colleagues’ criteria; AA lesions were graded I to III using Campanacci’s system. Outcomes included tumor recurrence and long-term remission. Overall, 29 patients met inclusion criteria (16 MF, 13 AA). Mean follow-up was 4.0±3.1 years. MF lesions more frequently received adjuvant pharmacologic therapy ( P <0.001), whereas surgical adjuvants were more common in AA lesions ( P =0.025). Recurrence occurred 6.2% of MF and 23.1% of AA lesions ( P =0.19). Remission was achieved in 100% of MF lesions and 76.9% of AA lesions ( P =0.13). All 5 grade III AA lesions either recurred or failed to achieve remission. Overall, MF GCLs were more likely to receive APT, whereas AA GCLs exhibited higher recurrence and lower remission rates. These findings highlight the importance of early identification of grade III AA lesions, which may require increased surveillance and the consideration of pharmacologic adjuvants. Ultimately, a tailored, multidisciplinary approach and the use of conservative surgical approaches with adjuvant therapy may reduce morbidity and optimize long-term outcomes.
Year:
2025
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (12)
Jenny Poynter
Professor
University of Minnesota
Robyn Gartrell
Assistant Professor of Pediatrics in Division of Pediatric Hematology/Oncology/SCT
Johns Hopkins University School of Medicine
Emily Christison-Lagay
Yale University
Peter Kuhn
Professor and Director
University of Southern California
Jin Piao
Associate Professor of Clinical
University of Southern California
Kenneth S. Chen
University of Texas Southwestern Medical Center
Lindsay Frazier
Professor and Institute Physician
Dana-Farber Cancer Institute
James Hicks
Professor
University of Southern California
Furqan Shaikh
Hospital for Sick Children
Jaclyn Biegel
Professor of Clinical Pathology
Children's Hospital of Los Angeles
Jesse Berry
Children's Hospital of Los Angeles
Joanna Gell
Assistant Professor
Connecticut Children's Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.